HOME >> MEDICINE >> NEWS
Chemoprevention backgrounder: Working for a future of cancer chemoprevention

-cell lung cancer, also contain a lot of COX-2, possibly because of the body's natural immune reaction to the cancer. Lotan found this year that, like some retinoids, NSAIDs may be effective in controlling cancer because they push cancerous cells to self-destruct.

In the ongoing placebo-controlled trial, which has accrued 85 patients so far, Kurie takes a biopsy of lung cells before, after and during the six-month study to see if twice-daily 400 milligrams doses of celecoxib can reverse damage due to smoking. "It's a biomarker study in which we will be able to see evidence of activity quickly," he says. "If positive, we will move on to a national study."

Not only is the power of COX-2 inhibitors being tested at M. D. Anderson in the number one cancer killer, lung cancer, but in the second deadliest national cancer - colorectal cancer.

And so far, it already has been proven to have an effect in people who inherit a form of colon cancer known as familial adenomatous polyposis (FAP), in which hundreds of precancerous polyps form in the colon and rectum. In 1999, the Food and Drug Administration (FDA) approved the use of celecoxib for FAP patients, based on work conducted at M. D. Anderson and St. Marks Hospital in London. In the study, led by Patrick Lynch, M.D., celecoxib reduced the number of polyps by 30 percent.

"It was an important event in the field of chemoprevention," says Levin. Colorectal cancer prevention trials do not focus on cancer occurrence, because of time constraints, but rather look at the incidence of adenomatous (glandular) polyps, which are known to increase colon cancer risk.

Based on that study, Lynch, an associate professor in the Department of Gastrointestinal Medicine and Nutrition, is heading another international trial in FAP looking at use of celecoxib combined with eflornithine (DFMO), a drug used to treat African sleeping sickness, but which is suspected of having anti-cancer properties. '"/>

Contact: Nancy Jensen
nwjensen@mdanderson.org
713-792-0655
University of Texas M. D. Anderson Cancer Center
16-Nov-2004


Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Cancer gene therapy news backgrounder: New ideas fuel next generation gene therapy research
2. Iressa news backgrounder: Testing of smart drug expands at M. D. Anderson Cancer Center
3. Cancer markers news backgrounder: Future of cancer diagnosis, treatment lies in tumor barcode
4. Working out may keep breast cells working well
5. PAHO Working With Affected Communities In Central America
6. Lupus Foundation Of America Awards Summer Internship To Student Working At Wistar Institute
7. Concerns over the future of childrens health care in British general practice
8. Engineers develop biowarfare sensing elements for future highly sensitive nerve-gas detectors
9. HIV vaccine trial breaks ground for future research
10. Climate change and the future of air travel
11. NIH action plan charts future challenges for liver disease research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/7/2020)... ... January 07, 2020 , ... ... for characterizing microbiome populations down to the strain level, has announced a ... organization. , TOMY provides high-quality instruments and services to industry segments including ...
(Date:1/7/2020)... ... January 07, 2020 , ... Red Oak ... Director of Foothills at Red Oak Recovery effective immediately. Ian began working ... the nation's leading residential treatment centers for adolescents. In this capacity, Ian worked ...
(Date:1/7/2020)... ... 06, 2020 , ... After 32 years in Stealth Mode, LumaCare ™ ... Duo ™. , The first public demonstrations of the LumaCare Duo will be given ... during CES 2020, the largest consumer electronics trade show and conference in the United ...
(Date:1/7/2020)... ... , ... R3 Stem Cell is now offering access to all regenerative training ... 24/7 and includes all the stem cell and exosome courses. , For several years, ... For the online regenerative training courses, R3 assembled all of the presentations and procedures ...
(Date:1/3/2020)... ... January 02, 2020 , ... ... lifestyle solutions, has announced the final round of U.S. finalists for its annual ... are Andrew Bischoff of Minnetonka, Minnesota; Ashley Pederson of St. Paul, Minnesota; Kim ...
Breaking Medicine News(10 mins):
(Date:1/7/2020)... , ... January 07, 2020 , ... ... enterprises and telecom service providers, announced today it has been selected by MetLife ... network infrastructure. , “As part of our ongoing commitment to maintain the ...
(Date:1/5/2020)... ... January 04, 2020 , ... The Voice First ... firms are fighting for leadership in both devices and voice assistant software. As ... during the past few years, multiple health-related voice assistants have been introduced, including ...
(Date:1/3/2020)... ... ... Stay on top of current hot topics through free webinars presented by leading ... free, so be sure to register today to save your place. Participate in the ... our upcoming webinars: , CLINICAL OPERATIONS , January 23 – The Benefits of a ...
Breaking Medicine Technology:
Cached News: